You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (862)

Journals (0)

1-10 of 862 results for Nucleoside reverse-transcriptase inhibitors

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Non-Nucleoside Reverse Transcriptase Inhibitors: The NNRTI Boom

Free access

Review article

First published 1999-12

Non-Nucleoside Reverse Transcriptase Inhibitors: The NNRTI Boom

Ole S Pedersen, Erik B Pedersen

Antiviral Chemistry and Chemotherapy

Select article: Efficacy of second-line dolutegravir plus 2 nucleoside reverse transcriptase inhibitors by baseline nucleoside reverse transcriptase inhibitor resistance and nucleoside reverse transcriptase inhibitor use in the DAWNING study

Open access

Research article

First published 2022-4

Efficacy of second-line dolutegravir plus 2 nucleoside reverse transcriptase inhibitors by baseline nucleoside reverse transcriptase inhibitor resistance and nucleoside reverse transcriptase inhibitor use in the DAWNING study

Dannae Brown, Richard Kaplan, Marcelo Losso [...]

Antiviral Therapy

Select article: A Diarylsulphone Non-Nucleoside Reverse Transcriptase Inhibitor with a Unique Sensitivity Profile to Drug-Resistant Virus Isolates

Free access

Research article

First published 1996-10

A Diarylsulphone Non-Nucleoside Reverse Transcriptase Inhibitor with a Unique Sensitivity Profile to Drug-Resistant Virus Isolates

R.W. Buckheit, V. Fliakas-Boltz, J.D. Russell [...]

Antiviral Chemistry and Chemotherapy

Select article: Emtricitabine: A Once-Daily Nucleoside Reverse Transcriptase Inhibitor

Retricted access

Research article

First published 2004-6

Emtricitabine: A Once-Daily Nucleoside Reverse Transcriptase Inhibitor

Krysten A Modrzejewski, Ronald A Herman

Annals of Pharmacotherapy

Select article: Apricitabine: A Nucleoside Reverse Transcriptase Inhibitor for HIV Infection

Retricted access

Research article

First published 2009-10

Apricitabine: A Nucleoside Reverse Transcriptase Inhibitor for HIV Infection

Monica M Gaffney, Paul P Belliveau, Linda M Spooner

Annals of Pharmacotherapy

Select article: Characterization of the Antiviral Activity of Highly Substituted Pyrroles: A Novel Class of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor

Free access

Research article

First published 1995-4

Characterization of the Antiviral Activity of Highly Substituted Pyrroles: A Novel Class of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor

T. Antonucci, J. S. Warmus, J. C. Hodges [...]

Antiviral Chemistry and Chemotherapy

Select article: Discontinuation of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy due to nucleoside analogue reverse transcriptase inhibitor-related metabolic toxicity

Retricted access

Research article

First published 2007-05

Discontinuation of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy due to nucleoside analogue reverse transcriptase inhibitor-related metabolic toxicity

International Journal of STD & AIDS

Select article: Nucleoside Reverse Transcriptase Inhibitor Usage and the Incidence of Peripheral Neuropathy in HIV/AIDS Patients

Free access

Research article

First published 2003-10

Nucleoside Reverse Transcriptase Inhibitor Usage and the Incidence of Peripheral Neuropathy in HIV/AIDS Patients

Gordana Dragovic, Djordje Jevtovic

Antiviral Chemistry and Chemotherapy

Select article: Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies

Free access

Research article

First published 2021-11

Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies

Jean Michel Molina, Luminita Ene, Pedro Cahn [...]

Antiviral Therapy

Select article: Indolylarylsulfones,a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors

Open access

Research article

First published 2018

Indolylarylsulfones,a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors

Valeria Famiglini, Romano Silvestri

Antiviral Chemistry and Chemotherapy

1
2
3
•••
87
10 / page

Article type

Publication date

Subjects

Access